These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15287737)

  • 1. Glycosaminoglycan disaccharide alters the dimer dissociation constant of the chemokine MIP-1 beta.
    McCornack MA; Boren DM; LiWang PJ
    Biochemistry; 2004 Aug; 43(31):10090-101. PubMed ID: 15287737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of N-terminal truncation and solution conditions on chemokine dimer stability: nuclear magnetic resonance structural analysis of macrophage inflammatory protein 1 beta mutants.
    Laurence JS; LiWang AC; LiWang PJ
    Biochemistry; 1998 Jun; 37(26):9346-54. PubMed ID: 9649315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of basic residues and quaternary structure in the function of MIP-1 beta: CCR5 binding and cell surface sugar interactions.
    Laurence JS; Blanpain C; De Leener A; Parmentier M; LiWang PJ
    Biochemistry; 2001 Apr; 40(16):4990-9. PubMed ID: 11305915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of the glycosaminoglycan binding site of chemokine macrophage-inflammatory protein-1 beta.
    Koopmann W; Ediriwickrema C; Krangel MS
    J Immunol; 1999 Aug; 163(4):2120-7. PubMed ID: 10438952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
    J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical modification of a variant of human MIP-1alpha; implications for dimer structure.
    Ashfield JT; Meyers T; Lowne D; Varley PG; Arnold JR; Tan P; Yang JC; Czaplewski LG; Dudgeon T; Fisher J
    Protein Sci; 2000 Oct; 9(10):2047-53. PubMed ID: 11106181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human CC chemokine MIP-1beta dimer is not competent to bind to the CCR5 receptor.
    Jin H; Shen X; Baggett BR; Kong X; LiWang PJ
    J Biol Chem; 2007 Sep; 282(38):27976-83. PubMed ID: 17644519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.
    Blanpain C; Buser R; Power CA; Edgerton M; Buchanan C; Mack M; Simmons G; Clapham PR; Parmentier M; Proudfoot AE
    J Leukoc Biol; 2001 Jun; 69(6):977-85. PubMed ID: 11404385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The binding surface and affinity of monomeric and dimeric chemokine macrophage inflammatory protein 1 beta for various glycosaminoglycan disaccharides.
    McCornack MA; Cassidy CK; LiWang PJ
    J Biol Chem; 2003 Jan; 278(3):1946-56. PubMed ID: 12411442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CC chemokine MIP-1 beta can function as a monomer and depends on Phe13 for receptor binding.
    Laurence JS; Blanpain C; Burgner JW; Parmentier M; LiWang PJ
    Biochemistry; 2000 Mar; 39(12):3401-9. PubMed ID: 10727234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural comparison of monomeric variants of the chemokine MIP-1beta having differing ability to bind the receptor CCR5.
    Kim S; Jao S; Laurence JS; LiWang PJ
    Biochemistry; 2001 Sep; 40(36):10782-91. PubMed ID: 11535053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of CC and CXC chemokine quaternary state mutants.
    Jin H; Hayes GL; Darbha NS; Meyer E; LiWang PJ
    Biochem Biophys Res Commun; 2005 Dec; 338(2):987-99. PubMed ID: 16256937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The seventh transmembrane domain of cc chemokine receptor 5 is critical for MIP-1beta binding and receptor activation: role of MET 287.
    Youn BS; Yu KY; Alkhatib G; Kwon BS
    Biochem Biophys Res Commun; 2001 Mar; 281(3):627-33. PubMed ID: 11237703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of the function of RANTES, MIP-1alpha, and MIP-1beta following interaction with heparin-like glycosaminoglycans.
    Ali S; Palmer AC; Banerjee B; Fritchley SJ; Kirby JA
    J Biol Chem; 2000 Apr; 275(16):11721-7. PubMed ID: 10766793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine receptor 5 and its ligands in the immune response to murine tuberculosis.
    Badewa AP; Quinton LJ; Shellito JE; Mason CM
    Tuberculosis (Edinb); 2005 May; 85(3):185-95. PubMed ID: 15850756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
    Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle.
    Blanpain C; Doranz BJ; Bondue A; Govaerts C; De Leener A; Vassart G; Doms RW; Proudfoot A; Parmentier M
    J Biol Chem; 2003 Feb; 278(7):5179-87. PubMed ID: 12466283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the role of the N-loop of MIP-1 beta in CCR5 binding.
    Bondue A; Jao SC; Blanpain C; Parmentier M; LiWang PJ
    Biochemistry; 2002 Nov; 41(46):13548-55. PubMed ID: 12427015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric regulation of CCR5 by guanine nucleotides and HIV-1 envelope.
    Staudinger R; Wang X; Bandrés JC
    Biochem Biophys Res Commun; 2001 Aug; 286(1):41-7. PubMed ID: 11485305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential sensitivities of pyrogenic chemokine fevers to CC chemokine receptor 5 antibodies.
    Tavares E; Miñano FJ
    Fundam Clin Pharmacol; 2004 Apr; 18(2):163-9. PubMed ID: 15066130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.